Why GeneDX Stock Is Plummeting Today

GeneDX (NASDAQ: WGS) banal is getting crushed successful Tuesday's trading. The biotech company's stock terms was down 48.7% arsenic of 11 a.m. ET.

GeneDX published its first-quarter results aft yesterday's marketplace close, posting income and net for the period that came successful acold worse than Wall Street had anticipated. Intensifying bearish pressures for the stock, the institution besides chopped its full-year guidance.

Will AI make the world's archetypal trillionaire? Our squad conscionable released a study connected the 1 little-known company, called an "Indispensable Monopoly" providing the captious exertion Nvidia and Intel some need. Continue »

GeneDX's Q1 study arrived with immoderate large informing signs

GeneDX recorded a non-GAAP (adjusted) nonaccomplishment of $0.28 per stock connected income of astir $102.3 cardinal successful the archetypal quarter. While income were inactive up astir 17% twelvemonth implicit year, they came successful astir $10.2 cardinal abbreviated of the mean Wall Street expert estimate.

Even worse, the business's adjusted nonaccomplishment per stock for the play came successful $0.26 higher than the level called for by the mean expert forecast. While exome and genome measurement accrued 34% twelvemonth implicit year, the institution faced a $5.5 cardinal income shortfall stemming from lower-than-expected mean reimbursement rates successful the class and a $6.5 cardinal shortfall successful the company's non-core concern lines.

What's adjacent for GeneDX?

In conjunction with its softer-than-expected Q1 performance, GeneDX chopped its full-year guidance. Management is present targeting income between $475 cardinal and $490 cardinal for the twelvemonth -- down from its erstwhile people for income between $540 cardinal and $555 million. Meanwhile, the mean expert estimation had targeted income of $550 cardinal for the period.

GeneDX's pricing powerfulness is looking importantly weaker coming retired of its Q1 report. In summation to the softer income outlook for the year, the institution is apt looking astatine a overmuch little adjusted nett -- truthful it's not astonishing investors are fleeing the banal today.

Should you bargain banal successful GeneDx close now?

Before you bargain banal successful GeneDx, see this:

The Motley Fool Stock Advisor expert squad conscionable identified what they judge are the 10 champion stocks for investors to bargain now… and GeneDx wasn’t 1 of them. The 10 stocks that made the chopped could nutrient monster returns successful the coming years.

Consider erstwhile Netflix made this database connected December 17, 2004... if you invested $1,000 astatine the clip of our recommendation, you’d person $490,864!* Or erstwhile Nvidia made this database connected April 15, 2005... if you invested $1,000 astatine the clip of our recommendation, you’d person $1,216,789!*